SCHEMBL15401158

SCHEMBL15401158

C=C(C(N)=O)c1nc(-c2ccccc2)c(C)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 2/20 0.49
RARB P10826 2/20 0.49
RARG P13631 2/20 0.49
GSTO1 P78417 1/20 0.49
XIAP P98170 1/20 0.48
ALOX5 P09917 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SCN9A Q15858 1/20 0.45
ROCK2 O75116 1/20 0.44
MAPK1 P28482 1/20 0.44
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3308450 0.84 SCN9A (0.57) RARARARBRARGGSTO1XIAP
SCHEMBL9830851 0.81 RARA (0.60) RARARARBRARGGSTO1XIAP
SCHEMBL18136488 0.76 RARA (0.51) RARARARBRARGGSTO1XIAP
SCHEMBL18136486 0.76 ALOX5 (0.61) RARARARBRARGGSTO1XIAP
SCHEMBL1435486 0.74 MAPT (0.56) RARARARBRARGGSTO1XIAP
SCHEMBL15401155 0.72 GSTO1 (0.48) RARARARBRARGGSTO1XIAP
SCHEMBL15401157 0.72 GSTO1 (0.48) RARARARBRARGGSTO1XIAP
SCHEMBL3310365 0.72 SCN9A (0.51) RARARARBRARGSMN1; SMN2ALDH1A1
SCHEMBL18215318 0.72 ALOX5 (0.72) GSTO1XIAPALOX5SMN1; SMN2ALDH1A1
SCHEMBL14736416 0.72 ALDH1A1 (0.53) RARARARBRARGGSTO1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424912-A1 2-AMINOTHIAZOLE DERIVATIVES FOR MEDICAL USE Huazhong University of Science and Technology (CN) 2019-01-09 EP disclosed
US-9771340-B2 2-aminothiazole derivatives and methods of preparing and using the same WUHAN INNAMUNE PHARMACEUTICAL CO., LTD. (CN) 2017-09-26 US disclosed
EP-2682390-A1 2-AMINOTHIAZOLE DERIVATIVE, PREPARATION METHOD, AND USE Huazhong University of Science and Technology (CN) 2014-01-08 EP disclosed
US-20140004155-A1 2-AMINOTHIAZOLE DERIVATIVES AND METHODS OF PREPARING AND USING THE SAME HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO., LTD. (CN) 2014-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140004155-A1 2-AMINOTHIAZOLE DERIVATIVES AND METHODS OF PREPARING AND USING THE SAME CCNT1, CCNE1, CCNT2 RARA 3523/4885RARB 3449/4885RARG 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.